BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 7655010)

  • 1. Fibrinopeptide A Family Biomarker Identification at Single Molecule Level.
    Balme S
    ACS Cent Sci; 2023 Feb; 9(2):131-133. PubMed ID: 36844484
    [No Abstract]   [Full Text] [Related]  

  • 2. Physiological fibrin hydrogel modulates immune cells and molecules and accelerates mouse skin wound healing.
    Pereira RVS; EzEldeen M; Ugarte-Berzal E; Martens E; Malengier-Devlies B; Vandooren J; Vranckx JJ; Matthys P; Opdenakker G
    Front Immunol; 2023; 14():1170153. PubMed ID: 37168862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional properties of individual sub-domains of the fibrin(ogen) αC-domains.
    Stohnii YM; Yatsenko TA; Nikulina VV; Kucheriavyi YP; Hrabovskyi OO; Slominskyi OY; Savchenko KS; Garmanchuk LV; Varbanets LD; Tykhomyrov AO; Chernyshenko VO
    BBA Adv; 2023; 3():100072. PubMed ID: 37082262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect on Cellular Vitality In Vitro of Novel APRF-Chlorhexidine Treated Membranes.
    Gavrailov T; Chenchev I; Gevezova M; Draganova M; Sarafian V
    J Funct Biomater; 2022 Nov; 13(4):. PubMed ID: 36412868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resuscitative Strategies to Modulate the Endotheliopathy of Trauma: From Cell to Patient.
    Wu F; Chipman A; Pati S; Miyasawa B; Corash L; Kozar RA
    Shock; 2020 May; 53(5):575-584. PubMed ID: 31090680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering microenvironment for human cardiac tissue assembly in heart-on-a-chip platform.
    Zhao Y; Rafatian N; Wang EY; Feric NT; Lai BFL; Knee-Walden EJ; Backx PH; Radisic M
    Matrix Biol; 2020 Jan; 85-86():189-204. PubMed ID: 30981898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporation of Collagen and Hyaluronic Acid to Enhance the Bioactivity of Fibrin-Based Hydrogels for Nucleus Pulposus Regeneration.
    Gansau J; Buckley CT
    J Funct Biomater; 2018 Jul; 9(3):. PubMed ID: 29996555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomaterials for the Delivery of Growth Factors and Other Therapeutic Agents in Tissue Engineering Approaches to Bone Regeneration.
    Kowalczewski CJ; Saul JM
    Front Pharmacol; 2018; 9():513. PubMed ID: 29896102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinopeptides A and B release in the process of surface fibrin formation.
    Riedel T; Suttnar J; Brynda E; Houska M; Medved L; Dyr JE
    Blood; 2011 Feb; 117(5):1700-6. PubMed ID: 21106983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinogen regulates the cytotoxicity of mycobacterial trehalose dimycolate but is not required for cell recruitment, cytokine response, or control of mycobacterial infection.
    Sakamoto K; Geisel RE; Kim MJ; Wyatt BT; Sellers LB; Smiley ST; Cooper AM; Russell DG; Rhoades ER
    Infect Immun; 2010 Mar; 78(3):1004-11. PubMed ID: 20028811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrin hydrogels for non-viral vector delivery in vitro.
    des Rieux A; Shikanov A; Shea LD
    J Control Release; 2009 Jun; 136(2):148-54. PubMed ID: 19232532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrin derived from patients with chronic thromboembolic pulmonary hypertension is resistant to lysis.
    Morris TA; Marsh JJ; Chiles PG; Auger WR; Fedullo PF; Woods VL
    Am J Respir Crit Care Med; 2006 Jun; 173(11):1270-5. PubMed ID: 16514114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGF-2 binding to fibrin(ogen) is required for augmented angiogenesis.
    Sahni A; Khorana AA; Baggs RB; Peng H; Francis CW
    Blood; 2006 Jan; 107(1):126-31. PubMed ID: 16160009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hemostatic system and angiogenesis in malignancy.
    Wojtukiewicz MZ; Sierko E; Klement P; Rak J
    Neoplasia; 2001; 3(5):371-84. PubMed ID: 11687948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of clot-associated (-derived) thrombin in cell proliferation induced by fibrin clots in vitro.
    Gandossi E; Lunven C; Berry CN
    Br J Pharmacol; 2000 Mar; 129(5):1021-7. PubMed ID: 10696104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell proliferation on fibrin: modulation by fibrinopeptide cleavage.
    Sporn LA; Bunce LA; Francis CW
    Blood; 1995 Sep; 86(5):1802-10. PubMed ID: 7655010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial cell spreading on fibrin requires fibrinopeptide B cleavage and amino acid residues 15-42 of the beta chain.
    Bunce LA; Sporn LA; Francis CW
    J Clin Invest; 1992 Mar; 89(3):842-50. PubMed ID: 1541676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial cell responses to fibrin mediated by FPB cleavage and the amino terminus of the beta chain.
    Francis CW; Bunce LA; Sporn LA
    Blood Cells; 1993; 19(2):291-306; discussion 306-7. PubMed ID: 8312565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots.
    Weisel JW; Veklich Y; Gorkun O
    J Mol Biol; 1993 Jul; 232(1):285-97. PubMed ID: 8331664
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.